Product Information
ONFI 10 MG TABLET is a brand product labeled by Lundbeck Pharmaceuticals LLC, priced at $29.9144 per EA under NDC 67386031401. Its NADAC has been published 649 times since Mar 19, 2014.
FDA first approved this application on Oct 21, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the clobazam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Lundbeck Pharmaceuticals LLCNDC
67386031401
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLOBAZAMApproval Type
New Drug (NDA)
FDA Application
NDA202067FDA Approved
10/21/2011
TE Code
AB
On Market Since
12/10/2013
Pharmacological Classes
Price Statistics
The NADAC for ONFI 10 MG TABLET has been published 649 times since Mar 19, 2014, and over the history we have for it it has risen 282.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $29.9144 per EA |
|---|---|
| All-time high | $30.0224 (Jul 16, 2025) |
| All-time low | $7.8229 (Mar 19, 2014) |
| 52-week high | $29.9653 |
| 52-week low | $29.9079 |
| Median price | $21.0495 |
| Average price | $20.5812 |
| Largest weekly change | +19.9% (Sep 16, 2015) |
| Weeks tracked | 649 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ONFI 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ONFI 10 MG TABLET, manufactured by Lundbeck Pharmaceuticals LLC, is $29.9144 per EA (NDC 67386031401), effective Aug 19, 2026.
How has the price of ONFI 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ONFI 10 MG TABLET has risen 282.4%. It has been tracked across 649 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for ONFI 10 MG TABLET?
Since Mar 19, 2014, the NADAC for ONFI 10 MG TABLET has ranged from a low of $7.8229 (Mar 19, 2014) to a high of $30.0224 (Jul 16, 2025), with a median of $21.0495 per EA.
Are there cheaper alternatives to ONFI 10 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBAZAM 10 MG TABLET, is $0.3590 per EA — about 99% below ONFI 10 MG TABLET.
Who manufactures ONFI 10 MG TABLET?
ONFI 10 MG TABLET (NDC 67386031401) is labeled by Lundbeck Pharmaceuticals LLC, and CMS classifies it as a brand product.